The Medicare Advantage and Part D Prescription Drug Programs
May 19, 2017
We appreciate the committee’s interest in strengthening the Medicare program and we welcome this opportunity to offer our comments on issues surrounding the Medicare Advantage (MA) and Medicare Part D prescription drug programs. Through their participation in the MA program, our members have a long track record in emphasizing prevention, providing access to disease management services for chronic conditions, implementing value-based care, and offering systems of coordinated care for ensuring that beneficiaries receive the health care services they need. Similarly, as sponsors of Part D plans, our members have demonstrated strong leadership in reducing medication errors, promoting clinically sound drug usage, and holding down costs for beneficiaries.